Retatrutide · For Type 2 diabetes

Retatrutide for Type 2 diabetes

A1C control with the next-gen GLP-1. Retatrutide for diabetes?

S-Tier (Phase 3) Weight Loss RCT (late-stage)

Why people use Retatrutide for Type 2 diabetes

A1C control with the next-gen GLP-1. Retatrutide for diabetes? The honest answer: promising - randomized trials are running and the early results lean positive. Phase-2 trial showed A1C drops of up to 2.0 percentage points at 36 weeks. The pivotal Phase-3 diabetes trial (TRIUMPH-2) is expected to read out Q2 to Q3 2026.

This page covers what's known, what's not, and what the editorial take is for normal humans considering Retatrutide for Type 2 diabetes.

What the evidence says

Evidence tier: RCT (late-stage). Late-stage human trials are reporting; FDA review pending. Real evidence, near-final.

Phase-2 trial showed A1C drops of up to 2.0 percentage points at 36 weeks. The pivotal Phase-3 diabetes trial (TRIUMPH-2) is expected to read out Q2 to Q3 2026.
Comparable or slightly better A1C control than Tirzepatide head-to-head.
FDA path includes the Type 2 diabetes indication; obesity NDA filing is expected 2026 with diabetes on a similar timeline.

Protocol notes

Same titration as for weight loss. Endocrinology coordination.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

You start at 2mg once a week and step up every 4 weeks. Trial doses ran 1mg up to 12mg weekly. One shot, under the skin, same day each week. The drug is not yet FDA-approved - most US users get compounded versions through telehealth. Always with a doctor.

Typical starting dose: 2 mg subQ (under-the-skin shot) once weekly for the first 4 weeks. Some prescribers start at 1 mg if the patient is sensitive to GLP-1 side effects.
Typical maintenance dose: Most users in TRIUMPH-1 settled between 4 mg and 12 mg weekly. The 8 mg and 12 mg arms produced the most weight loss.
Frequency: Once weekly. Same day each week.
Cycle length: Indefinite for chronic obesity or diabetes (assuming approval). Some users do 6 to 12 months for a defined goal.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full Retatrutide directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

New to peptides? Start with the foundations ->

Your next step

See the full Retatrutide dosing protocol Find your fit · 2-min quiz

Why people use Retatrutide for Type 2 diabetes

What the evidence says

Protocol notes

What to skip

Where to go next

Subscribe to the dispatch.